Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	High-Dose Ataluren	60
Overall Study	STARTED	Low-Dose Ataluren	57
Overall Study	STARTED	Placebo	57
Overall Study	As-treated Population	High-Dose Ataluren	60
Overall Study	As-treated Population	Low-Dose Ataluren	57
Overall Study	As-treated Population	Placebo	57
Overall Study	ITT Population	High-Dose Ataluren	60
Overall Study	ITT Population	Low-Dose Ataluren	57
Overall Study	ITT Population	Placebo	57
Overall Study	COMPLETED	High-Dose Ataluren	59
Overall Study	COMPLETED	Low-Dose Ataluren	57
Overall Study	COMPLETED	Placebo	57
Overall Study	NOT COMPLETED	High-Dose Ataluren	1
Overall Study	NOT COMPLETED	Low-Dose Ataluren	0
Overall Study	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00592553/flow